Home
About Us
Our Mission
Management
Board of Directors
Science Advisors
Science & Pipeline
Overview
Neuroplasticity
DMX-1001
Alcohol use disorder
Publications
Investors & Media
Media releases
News beats
For Investors
Media contact
Contact DemeRx
Press Release
DemeRx Awarded $1.7 Million National Institutes of Health Grant
DemeRx Appoints Biopharma Industry Veteran Vic Pirotsky to Board of Directors
DemeRx Joins Medical Psychedelics Working Group to Advance Next-Generation Addiction Treatments
DemeRx NB Inc. Advances Study for Alcohol Use Disorder Treatment
Menu
